In this Innovation Spotlight, Dan Levangie, president and chief executive officer of CereVasc, discusses a new treatment strategy for NPH using an endovascularly implantable CSF shunt that minimizes ...
Hydrocephalus is an excess of cerebrospinal fluid (CSF) in the brain’s ventricles. Surgery is the first-line and most effective treatment. The two primary surgeries are the Ventriculoperitoneal (VP) ...
When music legend Billy Joel revealed that he had been diagnosed with normal pressure hydrocephalus (NPH) in 2025, he did more than share a personal health update—he shed light on a little-known but ...
A landmark randomized, placebo-controlled trial provides the clearest evidence to date that shunt surgery benefits patients with idiopathic normal-pressure hydrocephalus (iNPH), a condition long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback